Hikma Pharmaceuticals Plc (HKMPY)
43.94
-0.66
(-1.48%)
USD |
OTCM |
Aug 24, 16:00
Hikma Pharmaceuticals Market Cap : 4.652B for Aug. 24, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 24, 2026 | 4.652B |
| August 21, 2026 | 4.722B |
| August 20, 2026 | 4.722B |
| August 19, 2026 | 4.722B |
| August 18, 2026 | 4.722B |
| August 17, 2026 | 4.802B |
| August 14, 2026 | 4.802B |
| August 13, 2026 | 4.893B |
| August 12, 2026 | 4.893B |
| August 11, 2026 | 4.893B |
| August 10, 2026 | 4.893B |
| August 07, 2026 | 4.893B |
| August 06, 2026 | 4.893B |
| August 05, 2026 | 4.606B |
| August 04, 2026 | 4.606B |
| August 03, 2026 | 4.606B |
| July 31, 2026 | 4.606B |
| July 30, 2026 | 4.606B |
| July 29, 2026 | 4.606B |
| July 28, 2026 | 4.606B |
| July 27, 2026 | 4.422B |
| July 24, 2026 | 4.369B |
| July 23, 2026 | 4.369B |
| July 22, 2026 | 4.449B |
| July 21, 2026 | 4.365B |
| Date | Value |
|---|---|
| July 20, 2026 | 4.360B |
| July 17, 2026 | 4.446B |
| July 16, 2026 | 4.446B |
| July 15, 2026 | 4.293B |
| July 14, 2026 | 4.220B |
| July 13, 2026 | 4.452B |
| July 10, 2026 | 4.451B |
| July 09, 2026 | 4.685B |
| July 08, 2026 | 4.685B |
| July 07, 2026 | 4.363B |
| July 06, 2026 | 4.363B |
| July 02, 2026 | 4.363B |
| July 01, 2026 | 4.365B |
| June 30, 2026 | 4.365B |
| June 29, 2026 | 4.538B |
| June 26, 2026 | 4.538B |
| June 25, 2026 | 4.538B |
| June 24, 2026 | 4.538B |
| June 23, 2026 | 4.383B |
| June 22, 2026 | 4.298B |
| June 18, 2026 | 4.298B |
| June 17, 2026 | 4.303B |
| June 16, 2026 | 4.458B |
| June 15, 2026 | 4.458B |
| June 12, 2026 | 4.458B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| AstraZeneca PLC | 526.09B |
| GSK Plc | 105.33B |
| Allergy Therapeutics Plc | 921.22M |
| Shield Therapeutics Plc | 75.32M |
| Futura Medical Plc | 3.255M |
Market Cap Related Metrics
| PE Ratio | 12.47 |
| PS Ratio | 1.412 |
| PEG Ratio | 0.3238 |
| Price to Free Cash Flow | 46.69 |
| Price | 43.94 |
| Earnings Yield | 8.02% |
| PEGY Ratio | 0.2939 |
| Operating PE Ratio | 7.206 |
| Normalized PE Ratio | 11.40 |